| Gene symbol | HSPB1 | Synonyms | CMT2F, HEL-S-102, HMN2B, HMND3, HS.76067, HSP27, HSP28, Hsp25, SRP27 | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q11.23 | dbXrefs | |
| Description | heat shock protein family B (small) member 1 | ||||
| GTO ID | GTC1352 |
| Trial ID | NCT01120470 |
| Disease | Prostate Cancer |
| Altered gene | Hsp27 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | OGX-427|Apatorsen |
| Co-treatment | Prednisone |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | A Randomized Phase II Study of OGX-427 (a Second-Generation Antisense Oligonucleotide to Heat Shock Protein-27) in Patients With Castration Resistant Prostate Cancer Who Have Not Previously Received Chemotherapy for Metastatic Disease |
| Year | 2010 |
| Country | Canada|United States |
| Company sponsor | British Columbia Cancer Agency |
| Other ID(s) | PR-01 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||